Sector: MedicalAmylin Pharmaceuticals, Inc. (NASDAQ: AMLN)
Headlines
- Amylin Pharmaceuticals Reports 2009 Financial Results
Jan 27, 2010 04:06 PM | AMLN
- Skymark Research Initiates Independent Research Coverage on Amylin Pharmaceuticals, Inc.
Jan 27, 2010 09:02 AM | AMLN
- Indices Roll Over Into The Close
Jan 26, 2010 05:13 PM | AMLN, BEXP, CAAS, CAGC, CSIQ, INCY
- Options Intelligence Report: Goldman-Bulls Foresee Greener Pastures By July
Jan 26, 2010 04:59 PM | AMLN, BKS, CAL, GS, KFT, LYV
- Amlylin Pharma (NASDAQ: AMLN): Upgraded To Buy At Citigroup
Jan 26, 2010 09:58 AM | AMLN, BCS, C, GS
- Amylin Pharmaceuticals to Webcast Year-End Financial Results
Jan 20, 2010 04:44 PM | AMLN
- San Antonio Fire and Police Pension Fund Announces Relief for Shareholders From Amylin Pharmaceuticals, Inc. "Proxy Puts"
Jan 20, 2010 12:25 PM | AMLN
- Tuesday's Breakout Stocks: Pumping Up Your Portfolio With NBTY
Jan 13, 2010 09:33 AM | AA, AMLN, BIG, CRL, GOOG, ILMN
- Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
Jan 11, 2010 07:00 PM | AMLN
- Amylin Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Jan 04, 2010 04:15 PM | AMLN
- ConjuChem announces U.S. Patent & Trademark Office issues final office action rejecting all claims in Amylin patent
Dec 21, 2009 08:53 PM | AMLN
- FDA: Byetta drug label is revised
Nov 02, 2009 04:05 PM | AMLN
- Domain Raises $500M Life Sciences Fund
Aug 11, 2009 03:57 PM | AMLN, CADX, OREX, SNTS, VOLC
- Amylin Pharmaceuticals Q2 Net Loss Narrows
Jul 27, 2009 06:51 AM | AMLN
- Citigroup, Wells Fargo, Boeing are big movers
Jan 28, 2009 06:23 PM | AAI, AMLN, BA, C, COP, GD
- Why Clean Tech Is Taking Biotech's Shine
Oct 07, 2008 10:53 AM | AMLN, ARNA, SGP, SNMX
- Market Alert: Wound Management Technologies -- January 13, 2010
Jan 13, 2010 09:56 AM | AMLN, BSX, ILMN, PFE
- BioCentury Publishes Investor Picks for New Biotech Bellwethers in 2010
Jan 11, 2010 07:54 AM | ACOR, AFFY, ALTH, AMGN, AMLN, DDSS
- The Fortune Financial Undertakes Review of Stocks in the Healthcare and Services Sectors
Nov 27, 2009 09:10 AM | AMLN, AMR, DAL, ILMN, LCC, VRTX
- Asterand Announces Agreement to Acquire BioSeek
Nov 18, 2009 03:52 AM | AMLN
- Amylin Pharmaceuticals Board of Directors Elects Paulo F. Costa Chairman of the Board
Aug 24, 2009 07:45 AM | AMLN
- Amylin Pharmaceuticals Reports Second Quarter Financial Results
Jul 21, 2009 04:06 PM | AMLN
- Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study
Jul 20, 2009 04:15 PM | ALKS, AMLN, LLY
- Amylin Pharmaceuticals to Webcast Second Quarter Results
Jul 14, 2009 04:06 PM | AMLN
- Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity
Jul 09, 2009 07:45 AM | AMLN
- New Drug Application for Exenatide Once Weekly Accepted for Review by FDA
Jul 07, 2009 04:05 PM | ALKS, AMLN, LLY
- Form 4 AMYLIN PHARMACEUTICALS For: Feb 02 Filed by: ROWLAND LLOYD A (10K)
Feb 04, 2010 08:10 PM
- Form 4 AMYLIN PHARMACEUTICALS For: Feb 02 Filed by: FOLETTA MARK G (10K)
Feb 04, 2010 08:10 PM
- Form 4 AMYLIN PHARMACEUTICALS For: Feb 02 Filed by: KOLTERMAN ORVILLE G (10K)
Feb 04, 2010 08:10 PM
- Form 4 AMYLIN PHARMACEUTICALS For: Feb 02 Filed by: MARCHETTI ROGER (10K)
Feb 04, 2010 08:10 PM
- Form 4 AMYLIN PHARMACEUTICALS For: Feb 02 Filed by: Lloyd Marcea Bland (10K)
Feb 04, 2010 08:09 PM
- Form 4 AMYLIN PHARMACEUTICALS For: Feb 02 Filed by: Mihalik Vincent P (10K)
Feb 04, 2010 08:09 PM
- Form 4 AMYLIN PHARMACEUTICALS For: Feb 02 Filed by: Marshall Paul (10K)
Feb 04, 2010 08:09 PM
- Form 4 AMYLIN PHARMACEUTICALS For: Feb 02 Filed by: Gergen Mark J (10K)
Feb 04, 2010 08:09 PM
- Form 4 AMYLIN PHARMACEUTICALS For: Feb 02 Filed by: BRADBURY DANIEL (10K)
Feb 04, 2010 08:09 PM
- Form 4 AMYLIN PHARMACEUTICALS For: Jan 11 Filed by: SULLIVAN JOSEPH P (10K)
Jan 12, 2010 07:45 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
AMLN
|
Compare to S&P
|
| YTD |
20.93 %
|
26.48 %
|
| 4 Weeks |
11.86 %
|
20.13 %
|
| 12 Weeks |
36.41 %
|
39.90 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -68.42 %
|
|
EPS Growth in Last Year: 11.11 %
|
|
Sales Growth in Last Quarter: -12.17 %
|
|
Sales Growth in Last Quarter: -8.38 %
|
|
